Dr. Stephanie R. Falatko, DO

Dr. Falatko practices at Parkview Regional Medical Center in Fort Wayne, Indiana, part of Parkview Health System.

Dr. Falatko's NPI, 1225321664, was assigned on May 18, 2011. Dr. Falatko holds Indiana license 02005129A.

Dr. Falatko's primary practice is Parkview Regional Medical Center, at 11109 Parkview Plaza Drive, Fort Wayne, IN 46845 in Allen County. The practice phone is (260) 266-1195.

Dr. Falatko's primary practice is Parkview Regional Medical Center in Fort Wayne, Indiana, part of Parkview Health System. Dr. Falatko is also affiliated with UAB Hospital. The medical group on file is Parkview Physicians Group. Dmand AI also links Dr. Falatko to 4 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Falatko practices, 7 sites in all. Vendor and product names are available with a free account.

Neurological surgery is Dr. Falatko's primary specialty in the NPI Registry, under taxonomy code 207T00000X. Dmand AI has Dr. Falatko's licenses on file in 3 states: Indiana, Alabama and Michigan.

CMS data shows 85 Medicare services from Dr. Falatko across 4 procedure codes in 2024, for 115 Medicare patients. Medicare paid $4,077 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 115 Medicare patients who saw Dr. Falatko in 2024. The largest group is 65 to 74, with 46 patients. 75% of them have high blood pressure, and 74% have high cholesterol. 17% are also on Medicaid. Their average risk score is 1.54, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Falatko's median patient age at 72, with 53% women.

In 2024, Dr. Falatko wrote 311 Medicare Part D claims for 83 patients. 69% of them were for generic drugs. CMS names the drug for 233 of them, across 6 drugs with 11 or more claims each, at $48,746 in total drug cost. In 2023, CMS named 134 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Falatko for performance year 2024, reported as part of a group. Dr. Falatko accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 43 procedures of spinal fusion by Dr. Falatko, more than 52% of the clinicians it reports for that procedure.

Dmand AI links 5 papers to Dr. Falatko, published from 2015 to 2018. 2015 was the busiest year, with 2. Dr. Falatko's most frequent co-authors are Mark R. Harrigan, Yaser Badr, MD and Richard Glenn Fessler, MD.

CMS Open Payments shows 128 general payments to Dr. Falatko from 28 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 72% of the total. Globus Medical, Inc. paid the most, $3,803. It also lists 1 research payment totaling $52 in 2019.